FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4241363911> ?p ?o ?g. }

• W4241363911 abstract "Background Invasive cervical carcinoma is preceded by a precancerous phase, cervical intra‐epithelial neoplasia (CIN), which can be detected on cervical smears and confirmed by colposcopy and biopsy. Moderate and severe intra‐epithelial neoplasia (CIN2 and CIN3) are treated mainly with surgery to prevent progression to invasive carcinoma. Medical methods of preventing the progression or inducing regression of CIN are needed. Retinoids are potent modulators of epithelial cell growth and differentiation and may have potential for the treatment of CIN. Objectives To ascertain whether retinoids can cause regression or prevent progression of CIN. Search methods We searched the Cochrane Gynaecological Cancer Review Group's Specialised Register and Non‐Trials Database, Cochrane Central Register of Controlled Trials (CENTRAL) (Issue 3,2010), MEDLINE and EMBASE (July 2010). Selection criteria Randomized controlled trials (RCTs) and non‐RCTs of retinoids for treating CIN in women. Data collection and analysis Two review authors independently assessed trial quality and extracted data from the trials. Adverse effects information was also collected from the trials. Main results Five RCTs comparing the efficacy of four different retinoids were identified. Two studies examined the effect on CIN2 and CIN3 of retinoids N‐(4‐hydroxyphenyl)retinamide (fenretinide) and 9‐cis‐retinoic acid (aliretinoin) given orally and two examined the effect of all‐trans‐retinoic acid given topically to the cervix. The fifth study investigated the use of 13‐cis‐retinoic acid (isotretinoin) given orally in HIV positive patients with CIN1 and condyloma. Four studies reported no significant effect of retinoids on the progression to higher grades of CIN, whilst the fifth did not report data on progression. In all studies retinoids had no significant effect on regression of CIN3. Two studies reported that retinoids were associated with regression of CIN2. One reported a greater complete regression of CIN2 over placebo, which was of borderline statistical significance, odds ratio (OR) 0.5 (95% confidence interval (CI) 0.25 to 1.02). The other study reported a non‐significant dose‐related trend towards increased rates of complete and partial regression compared with placebo. One study reported a significantly worse outcome in women receiving retinoid, OR for regression 6.00 (95% CI 1.00 to 35.91). In general, the retinoid medications were well tolerated. In this update no new studies were identified for inclusion. Authors' conclusions The retinoids studied are not effective at causing regression of CIN3 but may have some effect on CIN2. The data on CIN1 is inadequate. Retinoids are not effective at preventing progression of CIN of any grade. At the doses given and duration of treatment studied, the retinoids were reasonably well‐tolerated." @default.
• W4241363911 created "2022-05-12" @default.
• W4241363911 creator A5009339053 @default.
• W4241363911 creator A5051448050 @default.
• W4241363911 creator A5051583376 @default.
• W4241363911 creator A5054101570 @default.
• W4241363911 creator A5056976214 @default.
• W4241363911 date "2007-10-17" @default.
• W4241363911 modified "2023-09-27" @default.
• W4241363911 title "Retinoids for preventing the progression of cervical intra-epithelial neoplasia" @default.
• W4241363911 cites W1598602811 @default.
• W4241363911 cites W1644015069 @default.
• W4241363911 cites W1744285115 @default.
• W4241363911 cites W1904346042 @default.
• W4241363911 cites W1964224609 @default.
• W4241363911 cites W1966165057 @default.
• W4241363911 cites W1971792937 @default.
• W4241363911 cites W1976128743 @default.
• W4241363911 cites W1987445229 @default.
• W4241363911 cites W1988462585 @default.
• W4241363911 cites W1994561148 @default.
• W4241363911 cites W2011324475 @default.
• W4241363911 cites W2012603529 @default.
• W4241363911 cites W2013906649 @default.
• W4241363911 cites W2018581695 @default.
• W4241363911 cites W2023661530 @default.
• W4241363911 cites W2028078339 @default.
• W4241363911 cites W2034904824 @default.
• W4241363911 cites W2039979816 @default.
• W4241363911 cites W2049799621 @default.
• W4241363911 cites W2052369736 @default.
• W4241363911 cites W2060083452 @default.
• W4241363911 cites W2064213621 @default.
• W4241363911 cites W2065853108 @default.
• W4241363911 cites W2070000754 @default.
• W4241363911 cites W2071200701 @default.
• W4241363911 cites W2076448790 @default.
• W4241363911 cites W2086024380 @default.
• W4241363911 cites W2093262130 @default.
• W4241363911 cites W2112966757 @default.
• W4241363911 cites W2129632295 @default.
• W4241363911 cites W2140481064 @default.
• W4241363911 cites W2144359607 @default.
• W4241363911 cites W2161276770 @default.
• W4241363911 cites W2258484950 @default.
• W4241363911 cites W2339318589 @default.
• W4241363911 cites W44304557 @default.
• W4241363911 doi "https://doi.org/10.1002/14651858.cd003296.pub2" @default.
• W4241363911 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17943787" @default.
• W4241363911 hasPublicationYear "2007" @default.
• W4241363911 type Work @default.
• W4241363911 citedByCount "6" @default.
• W4241363911 countsByYear W42413639112012 @default.
• W4241363911 countsByYear W42413639112014 @default.
• W4241363911 countsByYear W42413639112023 @default.
• W4241363911 crossrefType "reference-entry" @default.
• W4241363911 hasAuthorship W4241363911A5009339053 @default.
• W4241363911 hasAuthorship W4241363911A5051448050 @default.
• W4241363911 hasAuthorship W4241363911A5051583376 @default.
• W4241363911 hasAuthorship W4241363911A5054101570 @default.
• W4241363911 hasAuthorship W4241363911A5056976214 @default.
• W4241363911 hasConcept C104317684 @default.
• W4241363911 hasConcept C121608353 @default.
• W4241363911 hasConcept C126322002 @default.
• W4241363911 hasConcept C143998085 @default.
• W4241363911 hasConcept C16005928 @default.
• W4241363911 hasConcept C168563851 @default.
• W4241363911 hasConcept C185592680 @default.
• W4241363911 hasConcept C197934379 @default.
• W4241363911 hasConcept C2775954498 @default.
• W4241363911 hasConcept C2776117191 @default.
• W4241363911 hasConcept C2776285725 @default.
• W4241363911 hasConcept C2777673923 @default.
• W4241363911 hasConcept C2777740455 @default.
• W4241363911 hasConcept C2778220009 @default.
• W4241363911 hasConcept C2780533455 @default.
• W4241363911 hasConcept C2781121885 @default.
• W4241363911 hasConcept C55493867 @default.
• W4241363911 hasConcept C71924100 @default.
• W4241363911 hasConcept C95190672 @default.
• W4241363911 hasConceptScore W4241363911C104317684 @default.
• W4241363911 hasConceptScore W4241363911C121608353 @default.
• W4241363911 hasConceptScore W4241363911C126322002 @default.
• W4241363911 hasConceptScore W4241363911C143998085 @default.
• W4241363911 hasConceptScore W4241363911C16005928 @default.
• W4241363911 hasConceptScore W4241363911C168563851 @default.
• W4241363911 hasConceptScore W4241363911C185592680 @default.
• W4241363911 hasConceptScore W4241363911C197934379 @default.
• W4241363911 hasConceptScore W4241363911C2775954498 @default.
• W4241363911 hasConceptScore W4241363911C2776117191 @default.
• W4241363911 hasConceptScore W4241363911C2776285725 @default.
• W4241363911 hasConceptScore W4241363911C2777673923 @default.
• W4241363911 hasConceptScore W4241363911C2777740455 @default.
• W4241363911 hasConceptScore W4241363911C2778220009 @default.
• W4241363911 hasConceptScore W4241363911C2780533455 @default.
• W4241363911 hasConceptScore W4241363911C2781121885 @default.
• W4241363911 hasConceptScore W4241363911C55493867 @default.
• W4241363911 hasConceptScore W4241363911C71924100 @default.
• W4241363911 hasConceptScore W4241363911C95190672 @default.
• W4241363911 hasLocation W42413639111 @default.

• next